Recent News
Building a Passion for Research: Q&A with CRFilMT Founder, Joseph Kamgno, MD, PhD,
Without partnerships, much – potentially all – global health work would be fruitless. That is why we decided to catch up with one of our
Blog – Entering the Global Arena: The Task Force’s New Non-State Actor in Official Relations Status with the WHO Brings Unique Opportunities for Collaboration
By: Lori Warrens, MedSurplus Alliance Director The World Health Organization (WHO) is an agency of the United Nations (UN) that serves as the UN coordination
Improving Quality of Care at the Core of Health System Strengthening
In 2013, the 90-90-90 goals were set to help end the global AIDS epidemic – by 2020, 90% of all people living with HIV will
Recent News
Building a Passion for Research: Q&A with CRFilMT Founder, Joseph Kamgno, MD, PhD,
Without partnerships, much – potentially all – global health work would be fruitless. That is why we decided to catch
Blog – Entering the Global Arena: The Task Force’s New Non-State Actor in Official Relations Status with the WHO Brings Unique Opportunities for Collaboration
By: Lori Warrens, MedSurplus Alliance Director The World Health Organization (WHO) is an agency of the United Nations (UN) that
Improving Quality of Care at the Core of Health System Strengthening
In 2013, the 90-90-90 goals were set to help end the global AIDS epidemic – by 2020, 90% of all
The Task Force family is made up of mission-driven professionals who are dedicated to health equity. If you think you would be a good fit, check out our opportunities.
The Task Force family is made up of mission-driven professionals who are dedicated to health equity. If you think you would be a good fit, check out our opportunities.
BAFANG, CAMEROON
is a 72-year-old river blindness patient in Cameroon’s Bafang district who has benefitted from The Task Force’s Mectizan® Donation Program (MDP) since 2004. She says the treatment has helped save her eyesight and she’s now able to look after her grandchildren. An estimated 205 million people, mostly in Africa, are at risk for river blindness. The disease is categorized as a neglected tropical disease (NTD) because the people it affects are among the most marginalized in society.
Ngo Yeba Anastasie, Beneficiary,
is a 72-year-old river blindness patient in Cameroon’s Bafang district who has benefitted from The Task Force’s Mectizan® Donation Program (MDP) since 2004. She says the treatment has helped save her eyesight and she’s now able to look after her grandchildren. An estimated 205 million people, mostly in Africa, are at risk for river blindness.
